ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,064.47
-1.01%
US Tech 100
17,118.00
-1.11%
Dow Jones
37,986.54
-1.04%
Brent Oil
86.055
-1.41%
Bitcoin
60,146.58
-5.78%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. HilleVax Inc (HLVX) Quote

HilleVax Inc

HilleVax Inc (HLVX)

NASDAQ
13.63
0.35
( 2.64% )
Updated: 12:59:08
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
13.63
Bid
13.55
Ask
13.63
Volume
19,424
13.04 Day's Range 13.63
9.94 52 Week Range 20.22
Market Cap
654.868M
Previous Close
13.28
Open
13.04
Last Trade
2
@
13.55
Last Trade Time
13:00:29
Financial Volume
$ 259,643
VWAP
13.3671
Average Volume (3m)
160,425
Shares Outstanding
48,437,001
Dividend Yield
-
PE Ratio
-5.30
Earnings Per Share (EPS)
-2.55
Revenue
-
Net Profit
-123.57M

About HilleVax Inc

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.hillevax.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
HilleVax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker HLVX. The last closing price for HilleVax was $13.28. Over the last year, HilleVax shares have traded in a share price range of $ 9.94 to $ 20.22.

HilleVax currently has 48,437,001 shares outstanding. The market capitalization of HilleVax is $654.87 million. HilleVax has a price to earnings ratio (PE ratio) of -5.30.

HLVX Latest News

More News

HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress

Topline data from NEST-IN1 Phase 2B clinical study of HIL-214 in infants expected in mid-2024 Enrollment for NEST-IN1 study completed in Q2 2023 $303.5 million of cash, cash equivalents and...

March 20 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

February 12 2024
Edgar (US Regulatory)

HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference

BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that...

February 05 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

January 26 2024
Edgar (US Regulatory)

HilleVax Taps Sean McLoughlin as Chief Operating Officer

By Ben Glickman HilleVax on Thursday named Sean McLoughlin as the vaccine developer's next operating chief. The Boston-based biopharmaceutical company said that co-founder and current COO...

January 18 2024
Dow Jones News

Form 8-K - Current report

January 18 2024
Edgar (US Regulatory)

HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer

BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...

January 18 2024
GlobeNewswire Inc.

Form 8-K - Current report

January 08 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.644.9268668206312.9913.6311.7913938312.76641011CS
4-2.27-14.276729559715.916.14511.7317450113.03735445CS
12-1.06-7.215793056514.6920.2211.7316042515.1155433CS
262.4722.132616487511.1620.2210.3714235414.88188402CS
52-0.37-2.642857142861420.229.9410964914.95822389CS
156-5.13-27.345415778318.7624.427.910516114.95534614CS
260-5.13-27.345415778318.7624.427.910516114.95534614CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AKLIAkili Inc
$ 0.3941
(67.77%)
78.14M
ELYMEliem Therapeutics Inc
$ 7.53
(50.00%)
2.7M
GMMGlobal Mofy Metaverse Ltd
$ 1.3889
(49.30%)
72.49M
CYCCCyclacel Pharmaceuticals Inc
$ 2.03
(49.26%)
18.97M
WGSGeneDx Holdings Corporation
$ 16.38
(48.91%)
5.55M
LICNLichen China Limited
$ 1.4127
(-30.41%)
996.65k
CETXCemtrex Inc
$ 1.26
(-29.21%)
296.89k
NRXPNRX Pharmaceuticals Inc
$ 2.6542
(-25.23%)
721.58k
NIVFNewGenIvf Group Ltd
$ 1.63
(-20.10%)
1.62M
LUCYInnovative Eyewear Inc
$ 0.197
(-18.22%)
375.24k
AGBAAGBA Group Holding Ltd
$ 3.24
(37.87%)
84.23M
TSLATesla Inc
$ 184.7765
(-4.78%)
84.02M
EGOXNext e GO NV
$ 0.0323
(17.03%)
81.48M
AKLIAkili Inc
$ 0.3941
(67.77%)
78.14M
JAGXJaguar Health Inc
$ 0.2271
(9.18%)
77.88M

Discussion

View Full Feed
Pumpadumphilus Pumpadumphilus 2 minutes ago
We did the same thing at .0016-.002. At lest we are higher here.
ILST
Twilson Twilson 2 minutes ago
Sounds like you have pulled your bear suit out maybe Shane was right .
ExtremelyBullishZig ExtremelyBullishZig 2 minutes ago
George...what do they know...?

The price just doesn't skyrocket like this for no reason...
AVXL
ChuckBits ChuckBits 3 minutes ago
"Ask not what Melvin can do for you, but what you can do for Melvin."
GDVM
buddynika buddynika 3 minutes ago
Thank You.
EBET
Vettelover98 Vettelover98 3 minutes ago
Hahahaha i think I will!! I’m excited! WE HAVE LIFTOFF!!! 🚀
BLEG
Gary 608 Gary 608 3 minutes ago
Shorters and MM's are the ones who are holding this down.
GMGI
Bizdevguy Bizdevguy 3 minutes ago
Yes
AABB
Awl416 Awl416 3 minutes ago
What leaked
TLRY
Invest-in-America Invest-in-America 3 minutes ago
MULN: Heck, I've been, ' mulling -this-one-over', for MONTHS now --- especially since Orion's "glenn1919" has been pumping it for YEARS!!

/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
MULN
rich2 rich2 3 minutes ago
From one of the most honest posters at Agoracom/lbsr; he does not encourage you to buy or sell(your decision) just presents facts as he sees them.

"Management said that they were very pleased with the drill results at HM."

Could anything else be said? I don't think so.
LBSR
hotdawg hotdawg 3 minutes ago
It's coming faster i was hopping. You may be able to get that vet you want sooner than later.
BLEG
FeMike FeMike 3 minutes ago
let’s not forget any other soul out there in the world who sees an approval for this and wants to fly to the UK for treatment.

I mean...you can pretty much forget them. Those numbers will be negligible. There's just not that many people that can afford to pay this cost out of pocket
NWBO
DjScottyT DjScottyT 4 minutes ago
0.000 is the result of being untruthful to shareholders. It’s not the result of those shareholders asking questions. Go ahead and post your 🤡 and other emojis. Guess it’s better than trying to prove me wrong. But but you were bullish 2 weeks ago. Don’t be a dummy. It’s a new account but I’ve
TSOI
jxyzobrien jxyzobrien 4 minutes ago
its easier to read then
a down chart and the brain sees it better
red means sell death oh no mr bill

sds daily bounced off 20da ma
https://schrts.co/vNhPSBJn
blackhawks blackhawks 4 minutes ago
Your a fool to tout poll numbers in May. Wait until Trump is convicted in NY.
pantherj pantherj 4 minutes ago
No, new shareholders can look back and educate themselves on what IFUS said, but continually fails to prove, happened. Empty promises and pitiful results .... those are what really happened. Which is the same thing that has happened every year since 2009.
IFUS
archilles archilles 5 minutes ago
I also suspect more ENZC ATM cashing is coming. More shares will be dumped by the pact of four or five as their dirty activities are being discovered and brought out to light.
PPS will take deeper hit when preferred shares got converted to common shares and then got cashed out.
Be rea
ENZC
tradernewstip tradernewstip 5 minutes ago
$RONN Loading Bottomed entry. https://finance.yahoo.com/quote/RONN
RONN
SmokeSignals SmokeSignals 5 minutes ago
adam schiffs luggage was found in Iran. lol
I-Glow I-Glow 5 minutes ago
The cult mentality is still strong - now the defense of Sharp for deregistering the stock.

Do you have any idea how many times I have seen these OTC scams file a Form 15 - and use the excuse that is For saving money - and the cult posts the same nonsense.

So you believe
GVSI WNFT
lucky, mydog lucky, mydog 5 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174288391&txt2find=rosen
PCTL
hotdawg hotdawg 6 minutes ago
Not yet they are due next month
BLEG
Dubster watching Dubster watching 6 minutes ago
Under $39 and I might look again. Junk
VZ
AJH92 AJH92 6 minutes ago
Great news - yet more progress on one of the multiple lines of business development that are on the go in 2024.

All explained in the authoritative Overview here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174200355

Here is the list of
PSRU

Your Recent History

NASDAQ
HLVX
HilleVax
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved